Get started
Author

Pia Davidsson

Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease
1999 · Niels Andreasen, Camilla Hesse, et al. · Archives of Neurology · 660
Evaluation of CSF-tau and CSF-Aβ42 as Diagnostic Markers for Alzheimer Disease in Clinical Practice
2001 · Niels Andreasen, Lennart Minthon, et al. · Archives of Neurology · 573
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization
2000 · E Vanmechelen, H Vanderstichele, et al. · Neuroscience Letters · 488
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke
2001 · Camilla Hesse, Lars Rosengren, et al. · Neuroscience Letters · 453
Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values
2001 · Magnus Sjögren, Hugo Vanderstichele, et al. · Clinical Chemistry · 436
Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples
2005 · Karin Björhall, Tasso Miliotis, et al. · PROTEOMICS · 384
Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease
2003 · Maja Puchades, Sara Folkesson Hansson, et al. · Molecular Brain Research · 306
Standardization of measurement of β-amyloid(1-42)in cerebrospinal fluid and plasma
2000 · Hugo Vanderstichele, Els Van Kerschaver, et al. · Amyloid · 301
CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
2000 · M. Sjögren, L. Minthon, et al. · Journal of Neural Transmission · 239
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
1999 · N. Andreasen, L. Minthon, et al. · Neuroscience Letters · 239
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study
1998 · N Andreasen, E Vanmechelen, et al. · Journal of Neurology Neurosurgery & Psychiatry · 227
PDF
Cerebrospinal Fluid Markers for Alzheimer's Disease Evaluated after Acute Ischemic Stroke
2000 · Camilla Hesse, Lars Rosengren, et al. · Journal of Alzheimer s Disease · 216
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
1999 · N. Andreasen, L. Minthon, et al. · Neurology · 212
Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele
1996 · K. Blennow, N. Bogdanovic, et al. · Journal of Neural Transmission · 206
Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients
2002 · Pia Davidsson, Ann Westman-Brinkmalm, et al. · Neuroreport · 200
Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds
2003 · I. Skoog, P. Davidsson, et al. · Dementia and Geriatric Cognitive Disorders · 194
Neurochemical Dissection of Synaptic Pathology in Alzheimer's Disease
1998 · Pia Davidsson, Kaj Blennow · International Psychogeriatrics · 182
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
2000 · M. Sjögren, L. Rosengren, et al. · Neurology · 180
Clusterin (Apolipoprotein J) Protein Levels Are Increased in Hippocampus and in Frontal Cortex in Alzheimer's Disease
1998 · A-M. Lidström, N. Bogdanovic, et al. · Experimental Neurology · 163
Cerebrospinal fluid levels of total-tau, phospho-tau and Aβ42 predicts development of Alzheimer's disease in patients with mild cognitive impairment
2003 · Niels Andreasen, Eugeen Vanmechelen, et al. · Acta Neurologica Scandinavica · 161
Decreased CSF-β-Amyloid 42 in Alzheimer’s Disease and Amyotrophic Lateral Sclerosis May Reflect Mismetabolism of β-Amyloid Induced by Disparate Mechanisms
2002 · Magnus Sjögren, Pia Davidsson, et al. · Dementia and Geriatric Cognitive Disorders · 145
Measurement of α- and β-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
2003 · Annika Olsson, Kina Höglund, et al. · Experimental Neurology · 133
The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process
2001 · Magnus Sjögren, Pia Davidsson, et al. · Dementia and Geriatric Cognitive Disorders · 122
Differential increase in cerebrospinal fluid-acetylcholinesterase after treatment with acetylcholinesterase inhibitors in patients with Alzheimer's disease
2001 · Pia Davidsson, Kaj Blennow, et al. · Neuroscience Letters · 111
Characterization of the binding epitope of a monoclonal antibody to sulphatide
1988 · P Fredman, L Mattsson, et al. · Biochemical Journal · 111
PDF
Works count: 139
Citation count: 10,710
H-index: 53
I10-index: 106
Year
Topic
Type